chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Radiculopathy, Viral test negative, Vitamin B12 normal
Clinical narrative: right leg paresthesia; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of Pfizer COVID 19 vaccine and experienced right leg paresthesia on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Positive COVID-19 rapid test; Positive COVID-19 rapid test; Positive COVID-19 rapid test; Patient got sick; 2 weeks of on and off fever and unproductive cough; Patient got sick; 2 weeks of on and off fever and unproductive cough; Patient got sick; 2 weeks of on and off fever and unproductive cough; Lost sense of taste and smell; Lost sense of taste and smell; sore throat; This is a spontaneous report from a contactable nurse (patient). A 50-year-old male patient received the 1st dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on 16Dec2020, at single dose, for COVID-19 immunisation. Medical history and concomitant medications were none. On 17Dec2020 patient got sick; 2 weeks of on and off fever and unproductive cough. In Dec2020 the patient also experienced lost sense of taste and smell. On 20Dec2020 the patient underwent COVID-19 rapid POC test and was found positive. The events required emergency room visit. Therapeutic measures were taken as a result of the events and included treatment with Tylenol 650 every 4 hours. The events recovered on unspecified date except unproductive cough and sore throat that were recovering.   The information on the lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (COVID-19 rapid POC test) with BNT162b2 can not be completely excluded.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Breast swelling, Lymphadenopathy, Myalgia, Swelling
Clinical narrative: Pain on bone and muscle; Pain on bone and muscle; Swelling of under arm, lymph nodes and breast; Swelling of under arm, lymph nodes and breast; Swelling of under arm, lymph nodes and breast; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unknown date as a single dose for COVID-19 vaccination. Relevant medical history and concomitant medication were not provided. On an unknown date, the patient experienced side effects such as pain on bone and muscle, swelling of under arm, lymph nodes and breast. The outcome of the events pain on bone and muscle, swelling of under arm, lymph nodes and breast was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vaccination site pain
Clinical narrative: headache; fever; injection site pain; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache, fever and injection site pain on an unspecified date after his first dose of the vaccine. Outcome of the events was unknown. The events were assessed as non-serious.  Information on batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid; Covid; This is a spontaneous report from a contactable Other Healthcare Professional (HCP).  A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient was scheduled for her second dose of vaccine tomorrow (08Jan2021) but she was diagnosed with Covid on 07Jan2021.  Outcome was unknown. Information on the lot/ batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Drug ineffective; tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist reporting for his/her mother-in-law. A 99-years-old female patient in good health received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on an unspecified date (presumably on 02Jan2021 - to be confirmed) at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included monoclonal antibody bamlanivimab on an unknown date. On 06Jan2021 the patient experienced tested positive for COVID-19. It was reported that the patient is scheduled to have her 2nd dose on 23Jan2021. The reporter asked if the patient should wait 90 days before taking the second dose.   Information on the lot/batch number has been requested.; Sender's Comments: A causal association between event and suspect BNT162B2 cannot be excluded
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature, Headache, Inappropriate schedule of product administration, Lymphoedema
Clinical narrative: The patient was a lactating mother; The patient was a lactating mother; Fever 102; Malaise; Headache; Body aches; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; 1st dose of BNT162B2 on 18Dec2020 13:15/2nd dose on 05Jan2021 13:45; This is a spontaneous report from a contactable other healthcare professional (patient) reported for both mother and baby. This is the maternal report. A 35-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration in left arm on 05Jan2021 13:45 at single dose for Covid-19 immunisation. Medical history included hx mild ehler's danlos syndrome, sulfa and latex sensitivity. No covid-prior-vaccination. No covid-tested-post-vaccination. The patient's concomitant medications included Prenatal. The patient previously received 1st dose of BNT162B2 (lot# EK5730) in left arm on 18Dec2020 13:15 for Covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever 102, malaise, severe headache and body aches, left axillary pain swelling - lymphedema on 06Jan2021 12:15. The patient was a lactating mother. The patient underwent lab tests and procedures which included body temperature: 102 on 06Jan2021. The outcome of events was recovering. This case was reported as non-serious.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021012166 child case
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Off label use, Pain, Product use issue, Pyrexia
Clinical narrative: The patient was a lactating mother; The patient was a lactating mother; Fever 102; Malaise; Headache; Body aches; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; 1st dose of BNT162B2 on 18Dec2020 13:15/2nd dose on 05Jan2021 13:45; This is a spontaneous report from a contactable other healthcare professional (patient) reported for both mother and baby. This is the maternal report. A 35-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration in left arm on 05Jan2021 13:45 at single dose for Covid-19 immunisation. Medical history included hx mild ehler's danlos syndrome, sulfa and latex sensitivity. No covid-prior-vaccination. No covid-tested-post-vaccination. The patient's concomitant medications included Prenatal. The patient previously received 1st dose of BNT162B2 (lot# EK5730) in left arm on 18Dec2020 13:15 for Covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever 102, malaise, severe headache and body aches, left axillary pain swelling - lymphedema on 06Jan2021 12:15. The patient was a lactating mother. The patient underwent lab tests and procedures which included body temperature: 102 on 06Jan2021. The outcome of events was recovering. This case was reported as non-serious.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021012166 child case
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: The patient was a lactating mother; The patient was a lactating mother; Fever 102; Malaise; Headache; Body aches; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; 1st dose of BNT162B2 on 18Dec2020 13:15/2nd dose on 05Jan2021 13:45; This is a spontaneous report from a contactable other healthcare professional (patient) reported for both mother and baby. This is the maternal report. A 35-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration in left arm on 05Jan2021 13:45 at single dose for Covid-19 immunisation. Medical history included hx mild ehler's danlos syndrome, sulfa and latex sensitivity. No covid-prior-vaccination. No covid-tested-post-vaccination. The patient's concomitant medications included Prenatal. The patient previously received 1st dose of BNT162B2 (lot# EK5730) in left arm on 18Dec2020 13:15 for Covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever 102, malaise, severe headache and body aches, left axillary pain swelling - lymphedema on 06Jan2021 12:15. The patient was a lactating mother. The patient underwent lab tests and procedures which included body temperature: 102 on 06Jan2021. The outcome of events was recovering. This case was reported as non-serious.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021012166 child case
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Inappropriate schedule of product administration
Clinical narrative: Fever 101.0F; chills; headache; fatigue; arm soreness; second dose on 05Jan2021 15:30 /first dose on 18Dec2020; This is a spontaneous report from an other hcp.  A 29-year-old female non-pregnant patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284), via an unspecified route of administration at left arm on 05Jan2021 15:30 at single dose for COVID-19 immunization. Facility type vaccine was Hospital. No known allergies. No other medical history. Concomitant medication included ibuprofen, alprazolam, ergocalciferol (VIT D), clarithromycin (CLARITIN), cranberry. No other vaccine in four weeks. The patient received first dose (lot number= EK5730) via an unspecified route of administration at Left arm on 18Dec2020 at single dose for COVID-19 immunization. The patient experienced Fever 101.0F, chills, headache, fatigue, arm soreness on 05Jan2021 20:00.  The patient underwent lab tests and procedures which included body temperature: 101.0 fahrenheit on 05Jan2021. No covid prior vaccination, Covid was test post vaccination via Nasal Swab on 22Dec2020 with result of negative. The events Fever 101.0F, chills, headache, fatigue, arm soreness were recovering. Treatment of acetaminophen received for the events Fever 101.0F, chills, headache, fatigue, arm soreness.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever 101.0F; chills; headache; fatigue; arm soreness; second dose on 05Jan2021 15:30 /first dose on 18Dec2020; This is a spontaneous report from an other hcp.  A 29-year-old female non-pregnant patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284), via an unspecified route of administration at left arm on 05Jan2021 15:30 at single dose for COVID-19 immunization. Facility type vaccine was Hospital. No known allergies. No other medical history. Concomitant medication included ibuprofen, alprazolam, ergocalciferol (VIT D), clarithromycin (CLARITIN), cranberry. No other vaccine in four weeks. The patient received first dose (lot number= EK5730) via an unspecified route of administration at Left arm on 18Dec2020 at single dose for COVID-19 immunization. The patient experienced Fever 101.0F, chills, headache, fatigue, arm soreness on 05Jan2021 20:00.  The patient underwent lab tests and procedures which included body temperature: 101.0 fahrenheit on 05Jan2021. No covid prior vaccination, Covid was test post vaccination via Nasal Swab on 22Dec2020 with result of negative. The events Fever 101.0F, chills, headache, fatigue, arm soreness were recovering. Treatment of acetaminophen received for the events Fever 101.0F, chills, headache, fatigue, arm soreness.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Inappropriate schedule of product administration
Clinical narrative: joint aches; tachycardia; chills; headache; nausea; lightheadedness; received BNT162B2, 1st dose and 2nd dose both in Jan2021 (before 07Jan2021); This is a spontaneous report from a contactable consumer. An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose and 2nd dose both in Jan2021 (before 07Jan2021) via an unspecified route of administration at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced joint aches, tachycardia, chills, headache, nausea, lightheadedness on an unspecified date of Jan2021. It was unknown if treatment received for events. The outcome of events was unknown. This case was reported as non-serious.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Tachycardia
Clinical narrative: joint aches; tachycardia; chills; headache; nausea; lightheadedness; received BNT162B2, 1st dose and 2nd dose both in Jan2021 (before 07Jan2021); This is a spontaneous report from a contactable consumer. An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose and 2nd dose both in Jan2021 (before 07Jan2021) via an unspecified route of administration at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced joint aches, tachycardia, chills, headache, nausea, lightheadedness on an unspecified date of Jan2021. It was unknown if treatment received for events. The outcome of events was unknown. This case was reported as non-serious.  Information on the lot/batch number has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Red, hot and raised at injection site.; Red, hot and raised at injection site.; Red, hot and raised at injection site.; Chills; Low grade fever; Fatigue; Body ache; This is a Spontaneous report from a contactable nurse (reported for herself). A 58-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO140), intramuscular on 04Jan2021 12:30 at single dose at right arm for COVID-19 immunization. Medical history included Vasculitis, no Allergies to medications, food, or other products. Concomitant medications received within 2 weeks of vaccination included azathioprine (IMURAN [AZATHIOPRINE]), chlorthalidone, duloxetine hydrochloride (CYMBALTA), hydroxychloroquine. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021 14:00, the patient experienced red, hot and raised at injection site. 18 hours after receiving, she developed chills, low grade fever, fatigue and body ache on 05Jan2021. Treatment received for the adverse events included Tylenol. This report was non-serious per the reporter. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was recovering.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Red, hot and raised at injection site.; Red, hot and raised at injection site.; Red, hot and raised at injection site.; Chills; Low grade fever; Fatigue; Body ache; This is a Spontaneous report from a contactable nurse (reported for herself). A 58-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO140), intramuscular on 04Jan2021 12:30 at single dose at right arm for COVID-19 immunization. Medical history included Vasculitis, no Allergies to medications, food, or other products. Concomitant medications received within 2 weeks of vaccination included azathioprine (IMURAN [AZATHIOPRINE]), chlorthalidone, duloxetine hydrochloride (CYMBALTA), hydroxychloroquine. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021 14:00, the patient experienced red, hot and raised at injection site. 18 hours after receiving, she developed chills, low grade fever, fatigue and body ache on 05Jan2021. Treatment received for the adverse events included Tylenol. This report was non-serious per the reporter. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus hypersecretion, SARS-CoV-2 test positive
Clinical narrative: positive with covid; positive with covid; sinus strainagned at the back of the throat.; sinus strainagned at the back of the throat.; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on an unspecified date single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced positive with COVID on an unspecified date, sinus strainagned at the back of the throat on an unspecified date. The outcome of the events was unknown. Information on the Batch/Lot number has been requested.; Sender's Comments: A causal association between reported "positive with covid" and suspect BNT162B2 cannot be excluded.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Off label use
Clinical narrative: Fever; Chills; Fatigue; Body Aches; Headache; Nausea; Other vaccine same date; Other vaccine same date; This is a spontaneous report from a contactable other health professional (patient). A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Jan2021 12:00 PM at single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were none. On the 06Jan2021, other vaccine was vaccinated on the same date at left arm. On 07Jan2021 09:00, patient experienced fever, chills, fatigue, body aches, headache, nausea. Treatment of events "fever, chills, fatigue, body aches, headache, nausea" was unknown. Outcome of "Other vaccine same date" was unknown, while outcome of other events was recovering.   Information on the lot/batch number has been requested.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Product use issue, Pyrexia
Clinical narrative: Fever; Chills; Fatigue; Body Aches; Headache; Nausea; Other vaccine same date; Other vaccine same date; This is a spontaneous report from a contactable other health professional (patient). A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Jan2021 12:00 PM at single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were none. On the 06Jan2021, other vaccine was vaccinated on the same date at left arm. On 07Jan2021 09:00, patient experienced fever, chills, fatigue, body aches, headache, nausea. Treatment of events "fever, chills, fatigue, body aches, headache, nausea" was unknown. Outcome of "Other vaccine same date" was unknown, while outcome of other events was recovering.   Information on the lot/batch number has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Off label use, Product use issue, Pyrexia
Clinical narrative: Fever; pregnant at the time of vaccination; pregnant at the time of vaccination/Other vaccine same date; pregnant at the time of vaccination; Other vaccine same date; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient (pregnant: yes) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: EH9899 and Expiration Date unknown) via unspecified route of administration on 06Jan2021 10:30 AM (Right arm) at single dose for COVID-19 immunization. No other vaccine in four weeks. The patient's medical history included Diabetes mellitus. No covid prior vaccination, no covid tested post vaccination and no Known allergies. The concomitant drug was reported as atorvastatin (LIPITOR), Metformin, clonazepam. After getting the vaccine (on 07Jan2021 15:00) patient was experiencing fever as a side effect. Patient had other vaccine same date. Patient was pregnant at the time of vaccination. No treatment was received. The outcome of event fever was not recovered.  Information on Lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; Headache; This is a spontaneous report from a contactable healthcare professional (patient). A 49-year-old female patient received the first dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer-BioNTech) lot no: EH9899, intramuscular in left arm on 06Jan2021 01:00 at a single dose for Covid-19 immunization in a hospital. The patient medical history and concomitant medications were not reported. The patient was not pregnant and no known allergies. No other vaccine was administered in four weeks. No Covid prior to vaccination and was not Covid tested post vaccination. The patient experienced nausea and headache on 06Jan2021 18:00. The events were reported as non-serious. Treatment was not given for the events. The patient was recovering from the events.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Inappropriate schedule of product administration, Influenza like illness, Malaise
Clinical narrative: Fever, chills, tiredness, feeling unwell, flu like symptoms; Fever, chills, tiredness, feeling unwell, flu like symptoms; Fever, chills, tiredness, feeling unwell, flu like symptoms; feeling unwell; Fever, chills, tiredness, feeling unwell, flu like symptoms; dose 1 received on 17Dec2020 while dose 2 received on 05Jan2021; This is a spontaneous report from a non-contactable nurse (patient). A 39-year-old non-pregnant female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), via an unspecified route of administration on 05Jan2021 15:30 at single dose in her right arm for covid-19 immunization. Medical history included hypertension. Concomitant medications the patient received within 2 weeks of vaccination included metoprolol and hydrochlorothiazide. The patient had known allergies to lisinopril and had historical vaccine included her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730) on 17Dec2020 15:30 in her right arm for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced fever, chills, tiredness, feeling unwell, flu like symptoms on 06Jan2021 15:30. The adverse events fever, chills, tiredness, feeling unwell, flu like symptoms result in any of the following included doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events fever, chills, tiredness, feeling unwell, flu like symptoms. The outcome of the events fever, chills, tiredness, feeling unwell, flu like symptoms was recovering.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever, chills, tiredness, feeling unwell, flu like symptoms; Fever, chills, tiredness, feeling unwell, flu like symptoms; Fever, chills, tiredness, feeling unwell, flu like symptoms; feeling unwell; Fever, chills, tiredness, feeling unwell, flu like symptoms; dose 1 received on 17Dec2020 while dose 2 received on 05Jan2021; This is a spontaneous report from a non-contactable nurse (patient). A 39-year-old non-pregnant female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), via an unspecified route of administration on 05Jan2021 15:30 at single dose in her right arm for covid-19 immunization. Medical history included hypertension. Concomitant medications the patient received within 2 weeks of vaccination included metoprolol and hydrochlorothiazide. The patient had known allergies to lisinopril and had historical vaccine included her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730) on 17Dec2020 15:30 in her right arm for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced fever, chills, tiredness, feeling unwell, flu like symptoms on 06Jan2021 15:30. The adverse events fever, chills, tiredness, feeling unwell, flu like symptoms result in any of the following included doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events fever, chills, tiredness, feeling unwell, flu like symptoms. The outcome of the events fever, chills, tiredness, feeling unwell, flu like symptoms was recovering.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Nausea, Palpitations
Clinical narrative: Palpitations; Chest pressure; Lightheadedness; Nausea; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on 23Dec2020 14:15 at left arm, at single dose for covid-19 immunization. Medical history included history of seizure, known allergies: topical Sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included (ascorbic acid) (VITAMIN C), (sambucus nigra) (ELDERBERRY), (linum usitatissimum seed oil) (FLAXSEED OIL), (allium sativum) (GARLIC). The patient previously took lamotrigine (LAMICTAL) and known allergies: LAMICTAL. The patient was not pregnant at the time of vaccination. The patient experienced palpitations, chest pressure, lightheadedness and nausea on 23Dec2020 14:15. The patient received Zofran and Meclizine given. Event resulted in: Emergency room. The outcome of the events was recovered on an unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Pain
Clinical narrative: Headache; Mental foggy; body aches; tired; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular in right arm on 06Jan2021 H 05:00 PM at single dose for COVID-19 immunization, lot number: EL3246. Medical history was reported as none. Patient had no known allergies and had no COVID prior vaccination. Patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications received within 2 weeks of vaccination included Antibiotic. On 07Jan2021 at 09:00 AM patient experienced headache, mental foggy, body aches and tired. She was not treated for the events. Patient had not been tested for COVID-19 post vaccination. Patient was recovering from the events at the time of the report.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pneumonia, Rash
Clinical narrative: received her 1st COVID vaccine shot 22Dec2020, however she got diagnosed with COVID; received her 1st COVID vaccine shot 22Dec2020, however she got diagnosed with COVID / pneumonia; rash; This is a spontaneous report from a contactable consumer (patient).  This 77-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 22Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. After the first dose, the patient got diagnosed with COVID. She does not want to waste a second dose if it will not be useful. Everyone on her department has had COVID, and have been told to wait 3 months before getting their second dose. Caller had a 'rash' after her 1st dose of the COVID vaccine. The patient is now recuperating from the pneumonia. Outcome of pneumonia was recovering while outcome of the other events was unknown. Information on the Lot/Batch Number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Diarrhoea, Dizziness
Clinical narrative: Fever; body aches; joint pain; headache; diarrhea; dizzy spells; uncontrollable shakes; chills; This is a spontaneous report from a Non-contactable Other Health Professional (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 06Jan2021 13:45 at single dose for COVID-19 immunization.  Medical history reported as none. Known allergies: NO (Allergies to medications, food, or other products: No). The patient's concomitant medications were not reported. List of any other medications the patient received within 2 weeks of vaccination: No. The patient experienced Fever, body aches, joint pain, headache, diarrhea, dizzy spells, uncontrollable shakes, chills, all on 06Jan2021 21:00 with outcome of recovering.  Pregnant at the time of vaccination: No. Facility where the most recent COVID-19 vaccine was administered: Hospital. If the patient received any other vaccines within 4 weeks prior to the COVID vaccine: No. No treatment received for the adverse event. Prior to vaccination, was the patient diagnosed with COVID-19: No. Since the vaccination, has the patient been tested for COVID-19: Yes. Covid test post vaccination: Nasal Swab on 07Dec2021 with result negative. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Serious: No. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: No. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Tremor
Clinical narrative: Fever; body aches; joint pain; headache; diarrhea; dizzy spells; uncontrollable shakes; chills; This is a spontaneous report from a Non-contactable Other Health Professional (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 06Jan2021 13:45 at single dose for COVID-19 immunization.  Medical history reported as none. Known allergies: NO (Allergies to medications, food, or other products: No). The patient's concomitant medications were not reported. List of any other medications the patient received within 2 weeks of vaccination: No. The patient experienced Fever, body aches, joint pain, headache, diarrhea, dizzy spells, uncontrollable shakes, chills, all on 06Jan2021 21:00 with outcome of recovering.  Pregnant at the time of vaccination: No. Facility where the most recent COVID-19 vaccine was administered: Hospital. If the patient received any other vaccines within 4 weeks prior to the COVID vaccine: No. No treatment received for the adverse event. Prior to vaccination, was the patient diagnosed with COVID-19: No. Since the vaccination, has the patient been tested for COVID-19: Yes. Covid test post vaccination: Nasal Swab on 07Dec2021 with result negative. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Serious: No. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: No. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hyperhidrosis, Lymphadenopathy, Nausea, Pain
Clinical narrative: nausea; vomiting; significant amount of diaphoresis; sudden onset of joint pain in upper torso involving fingers, elbows, and shoulders; Pain progressed into lower body; enlargement of the right supraclavicular lymph node; This is a spontaneous report from a contactable pharmacist(patient). A 37 years old female patient received second dose BNT162B2, Intramuscular on 05Jan2021 11:30 at the 37 years old at Arm Right at single dose for COVID-19 immunization. The medical history included Asthma and Seasonal Allergies. The concomitant medications were not reported. The patient previously took fist dose BNT162B2 on 16Dec2020 12:00 PM, Intramuscular at Arm Right at 37 years old for COVID-19 immunisation. The patient developed sudden onset of joint pain in upper torso involving fingers, elbows, and shoulders approximately 11 to 12 hours post immunization on 05Jan2021 23:00. Pain progressed into lower body throughout the night on 05Jan2021 23:00. The next morning, the pain increased to a point which caused severe nausea and vomiting on 06Jan2021. The patient received Toradol and Zofran to ease symptoms. After which, her husband was called to transport me home from work. The next 24 hours, the patient rested. During which, the patient experienced a significant amount of diaphoresis on 06Jan2021.  Forty-eight hours later, my symptoms are improving. I am sore, but functional. The only new occurrence is enlargement of the right supraclavicular lymph node in Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not Allergies to medications, food, or other products. The outcome of events was recovering.  The information on the batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: nausea; vomiting; significant amount of diaphoresis; sudden onset of joint pain in upper torso involving fingers, elbows, and shoulders; Pain progressed into lower body; enlargement of the right supraclavicular lymph node; This is a spontaneous report from a contactable pharmacist(patient). A 37 years old female patient received second dose BNT162B2, Intramuscular on 05Jan2021 11:30 at the 37 years old at Arm Right at single dose for COVID-19 immunization. The medical history included Asthma and Seasonal Allergies. The concomitant medications were not reported. The patient previously took fist dose BNT162B2 on 16Dec2020 12:00 PM, Intramuscular at Arm Right at 37 years old for COVID-19 immunisation. The patient developed sudden onset of joint pain in upper torso involving fingers, elbows, and shoulders approximately 11 to 12 hours post immunization on 05Jan2021 23:00. Pain progressed into lower body throughout the night on 05Jan2021 23:00. The next morning, the pain increased to a point which caused severe nausea and vomiting on 06Jan2021. The patient received Toradol and Zofran to ease symptoms. After which, her husband was called to transport me home from work. The next 24 hours, the patient rested. During which, the patient experienced a significant amount of diaphoresis on 06Jan2021.  Forty-eight hours later, my symptoms are improving. I am sore, but functional. The only new occurrence is enlargement of the right supraclavicular lymph node in Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not Allergies to medications, food, or other products. The outcome of events was recovering.  The information on the batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Neck pain, Vaccination site pain
Clinical narrative: Inability to move head; Shoulder and neck pain. Severe neck and shoulder pain day Seven; Shoulder and neck pain. Severe neck and shoulder pain day Seven; Severe pain at injection site; This is a spontaneous report from a contactable nurse  (Patient). A 37-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ685), via an unspecified route of administration in left arm on 23Dec2020 14:00 at single dose for covid-19 immunization in hospital. Medical history included ankylosing spondylitis. Known allergies included sulfa antibiotics. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient's concomitant medications were not reported. There was no vaccine in four weeks. The patient experienced severe pain at injection site on 24Dec2020 at 12: 00 PM for four days. Then on day 28Dec2020 and 29Dec2020, the patient experienced shoulder and neck pain. Severe neck and shoulder pain occurred on day 30Dec2020. The patient experienced inability to move head on an unspecified date. The patient went to doctor on 04Jan2021. The events result in doctor or other healthcare professional office/clinic visit. Treatment was unknown. The events were non-serious. The outcome of the events was unknow.
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain in jaw
Clinical narrative: hurts from his arm all the way through his neck and jaw and threw the rest of his body; hurts from his arm all the way through his neck and jaw and threw the rest of his body; hurts from his arm all the way through his neck and jaw and threw the rest of his body; This is a spontaneous report from a non contactable consumer. An adult male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced hurts from his arm all the way through his neck and jaw and threw the rest of his body on 07Jan2021 with outcome of recovering. He said it was worse than any flu he has ever felt. No therapeutic measures were taken as a result of the event. The event was considered as non serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Body height, Body temperature, Body temperature increased
Clinical narrative: achy knees/ achy joints/ achy right elbow; Headache; her temperature was 96, but not a fever; Achy back; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162B2 (Batch/lot number: EJ1685, Pfizer product), via an unspecified route of administration in in left arm on 06Jan2021 at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was receiving concomitant therapy. The patient previous received first dose of BNT162B2 on 08Dec2020 and experienced left arm a little sore at the injection site. The patient experienced achy knees/ achy joints/ achy right elbow, headache, her temperature was 96, but not a fever, achy back, all on 07Jan2021. She got her 2nd vaccine (COVID-19 Vaccine) on 06Jan2021 and this morning, the longer the morning goes on, she felt achy, has a headache, feels like she has a fever but does not. Had temperature taken this morning going into work and it was 93. Just now, her temperature was 96, but not a fever. She stated that this was nothing major, but the information she received said to call and report anything. First temperature taken this morning was from a forehead thermometer. The type of thermometer used for her second temperature this morning was not provided. She was a secretary for environmental services at the hospital she works at. She stated that she thought she could go to work and had to leave. She was going to bed as soon as she hangs up. Height: she used to be 5 feet 8 inches. She was counting on feeling better by tomorrow. She further described her achy feeling as her joints are achy including her knees, back and her elbow, but only her right elbow. She received the injection in her left arm. All she wanted to do now, was to crawl into a warm bed. She stated that she was fine after the first shot. Her arm was a little sore and that was it. She had her first COVID-19 Vaccine injection in her left arm. The soreness at the injection site lasted 2 days and then recovered completely. She did not provide her concomitant medications, stating that she took the same medications that she usually took and had not started anything new. She stated that she was 60 and has the what she had, but she did not have anything of concern; further stating that she had no breathing difficulties or anything like that. The patient underwent lab tests and procedures which included body height: 172.72 cm, body temperature: 93, body temperature: 96, all on an unspecified date. The outcome of events was not resolved.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: achy knees/ achy joints/ achy right elbow; Headache; her temperature was 96, but not a fever; Achy back; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162B2 (Batch/lot number: EJ1685, Pfizer product), via an unspecified route of administration in in left arm on 06Jan2021 at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was receiving concomitant therapy. The patient previous received first dose of BNT162B2 on 08Dec2020 and experienced left arm a little sore at the injection site. The patient experienced achy knees/ achy joints/ achy right elbow, headache, her temperature was 96, but not a fever, achy back, all on 07Jan2021. She got her 2nd vaccine (COVID-19 Vaccine) on 06Jan2021 and this morning, the longer the morning goes on, she felt achy, has a headache, feels like she has a fever but does not. Had temperature taken this morning going into work and it was 93. Just now, her temperature was 96, but not a fever. She stated that this was nothing major, but the information she received said to call and report anything. First temperature taken this morning was from a forehead thermometer. The type of thermometer used for her second temperature this morning was not provided. She was a secretary for environmental services at the hospital she works at. She stated that she thought she could go to work and had to leave. She was going to bed as soon as she hangs up. Height: she used to be 5 feet 8 inches. She was counting on feeling better by tomorrow. She further described her achy feeling as her joints are achy including her knees, back and her elbow, but only her right elbow. She received the injection in her left arm. All she wanted to do now, was to crawl into a warm bed. She stated that she was fine after the first shot. Her arm was a little sore and that was it. She had her first COVID-19 Vaccine injection in her left arm. The soreness at the injection site lasted 2 days and then recovered completely. She did not provide her concomitant medications, stating that she took the same medications that she usually took and had not started anything new. She stated that she was 60 and has the what she had, but she did not have anything of concern; further stating that she had no breathing difficulties or anything like that. The patient underwent lab tests and procedures which included body height: 172.72 cm, body temperature: 93, body temperature: 96, all on an unspecified date. The outcome of events was not resolved.